The Effect Of Macitentan On Long-Term Outcomes In Patients With Pulmonary Arterial Hypertension By Who Functional Class: Data From The Randomized Controlled Seraphin Study

被引：0
|
作者：
Channick, R. N. [1 ]
Delcroix, M. [2 ]
Galie, N. [3 ]
Ghofrani, H. A. [4 ,5 ]
Jansa, P. [6 ]
Le Brun, F. O. [7 ]
Mehta, S. [8 ]
Perchenet, L. [7 ]
Pulido, T. [9 ]
Sastry, B. [10 ]
Sitbon, O. [11 ]
Souza, R. [12 ]
Torbicki, A. [13 ]
Rubin, L. J. [14 ]
Simonneau, G. [11 ]
机构：
[1] Massachsetts Gen Hosp, Boston, MA USA
[2] Univ Hosp Gasthuisberg, Leuven, Belgium
[3] Univ Bologna, Bologna, Italy
[4] Univers Hosp Giessen & Marburg, German Ctr Lung Res, Giessen, Germany
[5] Imperial Coll London, Giessen, Germany
[6] Charles Univ Prague, Prague, Czech Republic
[7] Actel Pharmaceut Ltd, Allschwil, Switzerland
[8] Western Univ, London Hlth Sci Ctr, Victoria Hosp, London, ON, Canada
[9] Natl Inst Cardiol, Mexico City, DF, Mexico
[10] CARE Hosp, Hyderabad, Andhra Pradesh, India
[11] Univ Paris Sud, Hop Bicetre, Le Kremlin Bicetre, France
[12] Univ Sao Paulo, Inst Heart, Sao Paulo, Brazil
[13] ECZ Otwock, Ctr Postgrad Med Educ, Otwock, Poland
[14] Univ Calif San Diego, La Jolla, CA 92093 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2014年 / 189卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4783
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Adjusting Overall Survival Estimates of Macitentan in Pulmonary Arterial Hypertension After Treatment Switching: Results from the SERAPHIN Study
    Di Scala, Lilla
    Bacchi, Marisa
    Bayer, Bjorn
    Turricchia, Stefano
    ADVANCES IN THERAPY, 2022, 39 (09) : 4346 - 4358
  • [32] Long-term safety of macitentan in patients with pulmonary hypertension: A meta-analysis of randomised controlled trials
    Wang, Guizuo
    Qin, Jinlv
    Han, Dong
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2023,
  • [33] The Long-Term Outcomes In Patients With Exercise-Induced Pulmonary Arterial Hypertension
    Huang, W.
    Systrom, D.
    Waxman, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [34] Idiopathic Pulmonary Arterial Hypertension in Asians A Long-term Study on Clinical Outcomes
    Tan, Genevieve M. Y.
    Tay, Edgar L.
    Tai, Bee-Choo
    Yip, James W. L.
    CHEST, 2015, 147 (04) : E160 - E163
  • [35] REPAIR: long-term effects of macitentan on the right ventricle (RV) in pulmonary arterial hypertension (PAH)
    Kiely, David
    Cottreel, Emmanuelle
    Galie, Nazzareno
    Marcus, J. Tim
    Peacock, Andrew
    Rosenkranz, Stephan
    Swift, Andrew J.
    Tawakol, Ahmed
    Torbicki, Adam
    Noordegraaf, Anton Vonk
    Wetherill, Graham
    Channick, Richard
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [36] REPAIR: LONG-TERM EFFECTS OF MACITENTAN ON THE RIGHT VENTRICLE (RV) IN PULMONARY ARTERIAL HYPERTENSION (PAH)
    Kiely, D. G.
    Cottreel, E.
    Galie, N.
    Tarcus, J. T.
    Peacock, A.
    Rosenkranz, S.
    Swift, A. J.
    Tawakol, A.
    Torbicki, A.
    Noordegraaf, A. Vonk
    Wetherill, G.
    Channick, R.
    THORAX, 2021, 76 : A56 - A57
  • [37] Long-Term Outcomes With Ambrisentan Monotherapy in Pulmonary Arterial Hypertension
    Blalock, Shannon E.
    Matulevicius, Susan
    Mitchell, Laura C.
    Reimold, Sharon
    Warner, John
    Peshock, Ronald
    Torres, Fernando
    Chin, Kelly M.
    JOURNAL OF CARDIAC FAILURE, 2010, 16 (02) : 121 - 127
  • [38] Effect of selexipag on long-term outcomes in key subgroups of patients with pulmonary arterial hypertension (PAH): GRIPHON study results
    Sitbon, Olivier
    Channick, Richard
    Chin, Kelly
    Frey, Aline
    Galie, Nazzareno
    Ghofrani, Hossein-Ardeschir
    Hoeper, Marius M.
    Lang, Irene
    Le Brun, Franck-Olivier
    McLaughlin, Vallerie
    Preiss, Ralph
    Rubin, Lewis J.
    Simonneau, Gerald
    Tapson, Victor
    Gaine, Sean
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [39] SOPHA-Study: A prospective, randomized, controlled trial to assess the effect of long-term oxygen therapy on clinical paramters in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
    Echampati, I
    Xanthouli, P.
    Harutyunova, S.
    Eichstaedt, C.
    Egenlauf, B.
    Ulrich, S.
    Gruenig, E.
    Benjamin, N.
    PNEUMOLOGIE, 2024, 78 : S54 - S55
  • [40] Is 6-minute walk distance (6MWD) associated with long-term outcomes in pulmonary arterial hypertension (PAH)? Results from SERAPHIN
    Delcroix, Marion
    Channick, Richard
    Galie, Nazzareno
    Ghofrani, Hossein-Ardeschir
    Jansa, Pavel
    Le Brun, Franck-Olivier
    Mehta, Sanjay
    Perchenet, Loic
    Pulido, Tomas
    Sastry, B. K. S.
    Sitbon, Olivier
    Souza, Rogerio
    Torbicki, Adam
    Simonneau, Gerald
    Rubin, Lewis
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
12345